[Changes of heart geometry in patients with ischemic heart disease]

Dalia Pangonyte1, Elena Stalioraityte, Danute Kazlauskaite

  • 1Laboratory of Cardiac Pathology, Institute of Cardiology, Kaunas University of Medicine, Kaunas, Lithuania. dalia.pangonyte@med.kmu.lt

Insights

This study investigated heart changes in ischemic heart disease patients. Preinfarction showed increased heart mass and dimensions, while postinfarction revealed further left ventricular and atrial enlargement.

Area of Science:

  • Cardiology
  • Pathology
  • Cardiac Anatomy

Background:

  • Ischemic heart disease (IHD) is a leading cause of mortality.
  • Understanding cardiac remodeling in IHD is crucial for prognosis.
  • Previous studies have not fully detailed cardiometric changes across IHD stages.

Purpose of the Study:

  • To determine ventricular and atrial cardiometric parameters in preinfarction and postinfarction stages of IHD.
  • To investigate changes in heart mass, endocardial surface area, and flow/outflow tracts.
  • To characterize hypertrophy patterns in different cardiac chambers during IHD progression.

Main Methods:

  • Postmortem investigation of 132 men who died suddenly from IHD.
  • Patients were divided into preinfarction (n=71) and postinfarction (n=61) groups.
  • Exclusion of factors predisposing to hypertrophy and heart failure symptoms.

Main Results:

  • Preinfarction stage: increased mass and endocardial surface area in all heart chambers; longer flow and outflow tracts.
  • Postinfarction stage: further increases in left ventricular and atrial parameters.
  • Eccentric left ventricular hypertrophy and concentric right ventricular/atrial hypertrophy observed preinfarction.

Conclusions:

  • Preinfarction IHD is characterized by eccentric LVH and concentric RV/atrial hypertrophy.
  • Postinfarction IHD shows progression primarily in left ventricular and atrial dimensions.
  • These findings highlight distinct cardiac remodeling patterns in IHD progression.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...